Improved <i>Helicobacter pylori</i> Eradication Rate of Tailored Triple Therapy by Adding <i>Lactobacillus delbrueckii</i> and <i>Streptococcus thermophilus</i> in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial

<div>Flow diagram showing numbers of patients enrolled and missed for per protocol and intention-to-treat analyses. ITT: intention-to-treat; PP: per protocol. Group 1: triple therapy alone, group 2: pretreatment probiotic, and group 3: posttreatment probiotic.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Improved <i>Helicobacter pylori</i> Eradication Rate of Tailored Triple Therapy by Adding <i>Lactobacillus delbrueckii</i> and <i>Streptococcus thermophilus</i> in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial 

Figure 2 | Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial 